tirzepatide glp-1 drops FDA says shortage of drug is over Tirzepatide Archives - Drug Discovery

After a number of years of robust revenue growth right after the pandemic, states are starting to see slowing revenues, increasing spending demands and a lot of fiscal uncertainty due in part to recent federal actions. In April, the Trump administration scrapped a Biden-era proposal that would have required state Medicaid programs to pay for some GLP-1s for obesity treatment

What were reading As abortion opponents target IVF, theyre promoting fertility clinics like this one, The 19th Dementia housing without locked wards

Rather than viewing telehealth platforms as competitors, clinicians can position themselves as partners in care

[8] Metformin with GLP-RA & Long-term Outcomes: In patients with T2D, dual therapy with metformin and GLP-RA has demonstrated a 39% lower incidence of adiposity-related cancers (HR 0.61) and a 67% reduction in all-cause mortality (HR 0.33) compared to DPP-4 inhibitor use, with effects most pronounced in younger people with obesity